The economic value of knowing BRCA status: BRCA testing for optimizing treatment in recurrent epithelial ovarian cancer.

Expert review of pharmacoeconomics & outcomes research(2023)

Cited 0|Views17
No score
Abstract
The economic value of knowing status of all U.S. ROC patients provides short-term and long-term evidence for optimizing treatment.
More
Translated text
Key words
BRCA,BRCA1,BRCA2,cost-effectiveness,olaparib,ovarian cancer,recurrent epithelial ovarian
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined